CG
MBII

Cutler Group’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Cutler Group’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,320
Closed -$1K – 7014
2017
Q2 		$1K Hold
1,320
– – ﹤0.01% 6122
2017
Q1 		$2K Hold
1,320
– – ﹤0.01% 5629
2016
Q4 		$2K Hold
1,320
– – ﹤0.01% 5768
2016
Q3 		$2K Hold
1,320
– – ﹤0.01% 5877
2016
Q2 		$1K Hold
1,320
– – ﹤0.01% 6381
2016
Q1 		$1K Hold
1,320
– – ﹤0.01% 6221
2015
Q4 		$1K Buy
+1,320
New +$2.83K ﹤0.01% 6175

Other funds holding MBII

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Azimuth Capital Management Bloomfield Hills, Michigan $2.34B AUM 16.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Cutler Group's MBII Position: Q3 2017 in Review

Cutler Group sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2017, closing a stake of 1,320 shares — an estimated $1K sold.

Cutler Group first reported a position in MBII in Q4 2015 and held it in 7 quarters. The position peaked at $2K in Q1 2017. 23 funds tracked by Wall St. Rank hold MBII as of Q3 2017.

  • Cutler Group reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2017 after selling out during the quarter.
  • Cutler Group sold 1,320 Marrone Bio Innovations, Inc. shares in Q3 2017, an estimated $1K.
  • Cutler Group first reported a position in Marrone Bio Innovations, Inc. in Q4 2015 and held it in 7 quarters.
  • Cutler Group's Marrone Bio Innovations, Inc. position peaked at $2K in Q1 2017.
  • 23 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2017.

Based on Cutler Group's 13F filing for Q3 2017, filed 17 Oct 2017.